Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

BMC Cancer. 2024 Jan 23;24(1):114. doi: 10.1186/s12885-024-11863-0.
No abstract available

Publication types

  • Published Erratum